SCHEMBL1615335

SCHEMBL1615335

COCCC1C(=O)N(c2cnn(Cc3c(C)noc3C)c2)C(=O)N1Cc1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TAS2R8 Q9NYW2 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10248683 0.87 TAS2R8 (0.76) TAS2R8
SCHEMBL1279205 0.85 TAS2R8 (1.00) TAS2R8
SCHEMBL1279690 0.85 TAS2R8 (1.00) TAS2R8
SCHEMBL1279209 0.85 TAS2R8 (1.00) TAS2R8
SCHEMBL1279459 0.80 TAS2R8 (1.00) TAS2R8
SCHEMBL1616758 0.80 TAS2R8 (0.87) TAS2R8
SCHEMBL1279189 0.79 TAS2R8 (1.00) TAS2R8
SCHEMBL1279197 0.79 TAS2R8 (1.00) TAS2R8
SCHEMBL12290404 0.79 TAS2R8 (0.84) TAS2R8
SCHEMBL27977928 0.77 TAS2R8 (0.69) TAS2R8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088796-A1 COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND USE THEREOF SENOMYX, INC. (US) 2012-04-12 — — US disclosed
US-20120088796-A1 COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND USE THEREOF SENOMYX, INC. (US) 2012-04-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088796-A1 COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND USE THEREOF TAS2R50, TAS2R5, TAS2R1 TAS2R8 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback